Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127737301 | 12773730 | 1 | I | 2016 | 20160708 | 20160923 | 20160923 | EXP | CA-ORION CORPORATION ORION PHARMA-TREX2016-1041 | ORION | 60.00 | YR | M | Y | 0.00000 | 20160923 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127737301 | 12773730 | 1 | PS | METHOTREXATE (TRADE NAME UNKNOWN) | METHOTREXATE | 1 | Oral | 0 | 25 | MG | TABLET | /wk | |||||||
| 127737301 | 12773730 | 2 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 0 | 5 | MG | TABLET | BID | |||||||
| 127737301 | 12773730 | 3 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 0 | 5 | MG | TABLET | ||||||||
| 127737301 | 12773730 | 4 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 0 | 5 | MG | TABLET | BID | |||||||
| 127737301 | 12773730 | 5 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 0 | 1 | G | TABLET | BID | |||||||
| 127737301 | 12773730 | 6 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127737301 | 12773730 | 1 | Rheumatoid arthritis |
| 127737301 | 12773730 | 2 | Rheumatoid arthritis |
| 127737301 | 12773730 | 5 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127737301 | 12773730 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127737301 | 12773730 | Bile duct stone | |
| 127737301 | 12773730 | Cholelithiasis | |
| 127737301 | 12773730 | Nausea | |
| 127737301 | 12773730 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127737301 | 12773730 | 1 | 201509 | 0 | ||
| 127737301 | 12773730 | 2 | 20160617 | 2016 | 0 | |
| 127737301 | 12773730 | 3 | 201607 | 201607 | 0 | |
| 127737301 | 12773730 | 4 | 2016 | 20160816 | 0 | |
| 127737301 | 12773730 | 5 | 201509 | 201607 | 0 |